Top Page
NobleOak Life Ltd
(Sydney:NOL)
NobleOak Life Ltd (NOL) vs. iShares MSCI Australia ETF (EWA)
NobleOak Life Ltd Business Overview & Revenue Model
NobleOak Life Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 123.99M | 123.99M | 386.65M | 343.40M | 75.43M | 61.32M |
| Gross Profit | 123.99M | 123.99M | 50.26M | 181.86M | 169.78M | 61.32M |
| EBITDA | 15.42M | 15.42M | 20.33M | 18.67M | 4.22M | 8.52M |
| Net Income | 7.12M | 7.12M | 9.28M | 7.99M | 1.69M | 4.90M |
Balance Sheet | ||||||
| Total Assets | 567.29M | 567.29M | 463.73M | 251.15M | 121.08M | 72.62M |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 0.00 | 63.96M | 30.26M | 30.26M | 31.41M |
| Total Debt | 4.58M | 4.58M | 5.26M | 5.83M | 556.00K | 1.46M |
| Total Liabilities | 478.36M | 478.36M | 392.33M | 131.31M | 9.45M | -12.00M |
| Stockholders Equity | 88.94M | 88.94M | 71.41M | 119.84M | 111.63M | 84.62M |
Cash Flow | ||||||
| Free Cash Flow | 58.63M | 58.63M | 44.02M | 129.66M | 23.49M | -2.17M |
| Operating Cash Flow | 58.74M | 58.74M | 44.42M | 130.14M | 27.98M | -720.00K |
| Investing Cash Flow | -45.59M | -45.59M | -29.86M | -108.81M | -53.33M | -10.37M |
| Financing Cash Flow | 8.44M | 8.44M | -1.01M | -1.18M | 23.77M | 14.42M |
NobleOak Life Ltd Technical Analysis
NobleOak Life Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | AU$142.20M | 18.50 | 8.88% | ― | 21.79% | -23.00% | |
56 Neutral | AU$342.21M | 46.77 | 4.50% | ― | 0.63% | ― | |
56 Neutral | AU$929.04M | 9.31 | 12.11% | 11.71% | -6.49% | -5.40% | |
55 Neutral | AU$434.31M | 21.79 | 12.36% | 2.86% | -26.30% | 40.12% | |
53 Neutral | AU$773.77M | 17.27 | 5.92% | 4.63% | 26.01% | -17.55% | |
50 Neutral | AU$4.52B | 57.05 | 14.42% | ― | 23.69% | 116.67% |
NobleOak Life Ltd Corporate Events
NobleOak Life Limited has announced a change in the director’s interest, specifically regarding Anthony Ross Brown’s holdings. The change involves the acquisition of 343,156 performance rights, which were approved by shareholders, reflecting a strategic move to align executive interests with company performance. This adjustment in director’s interests may impact the company’s governance and stakeholder confidence, as it underscores a commitment to performance-based incentives.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Ltd announced the issuance of 1,049,684 unquoted performance rights under an employee incentive scheme. These securities are subject to transfer restrictions and will not be quoted on the ASX until the restrictions are lifted, potentially impacting employee retention and motivation strategies.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Ltd recently held its Annual General Meeting, where several key resolutions were passed. These included the adoption of the Remuneration Report, the re-election of directors Inese Kingsmill and Stephen Harrison, and the approval of a Long Term Incentive Plan for the CEO for FY26. The outcomes of these resolutions indicate strong shareholder support for the company’s leadership and strategic plans, which could positively impact its market positioning and stakeholder confidence.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Ltd has announced its 2025 Annual General Meeting, highlighting its position as Australia’s fastest-growing direct life insurer. The announcement underscores the company’s robust growth trajectory and its strategic focus on enhancing its market presence, which is likely to have positive implications for its stakeholders.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Limited reported a strong financial performance for FY25, with a 20% increase in in-force premiums to $464 million and a 22% rise in underlying NPAT to $18.3 million. The company continues to strengthen its position as a leading direct life insurer in Australia, driven by a diversified strategy, direct distribution model, and investment in technology and product innovation. A significant strategic development was the transition from a Friendly Society to a Life Company structure, aiming for cost-effective capital management and improved governance. This transition, requiring a $3-4 million investment, positions NobleOak for future growth in life insurance and wealth markets. Despite not declaring a dividend for FY25, the Board anticipates potential dividend payments by 2027, contingent on ongoing strong performance.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Limited has announced the appointment of Amanda Underwood as its new Company Secretary, effective November 20, 2025. This strategic appointment is expected to strengthen the company’s governance and operational framework, potentially enhancing its industry positioning and stakeholder confidence.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Limited has announced a change in the director’s interest, specifically concerning Andrew Crawfurd Gale. The change involves the acquisition of 25,345 ordinary shares, increasing his total holdings to 80,000 shares. This transaction, conducted through an on-market trade, reflects a strategic move in managing personal investments and may indicate confidence in the company’s future performance.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Limited has announced a change in the director’s interest, with Andrew Crawfurd Gale acquiring an additional 4,172 ordinary shares through an on-market trade. This transaction increases his total holdings to 54,655 shares, reflecting a continued commitment to the company and potentially signaling confidence in its future performance.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Limited has announced its Annual General Meeting (AGM) scheduled for 21 November 2025, which will be conducted in a hybrid format allowing both in-person and online participation. This meeting provides shareholders an opportunity to engage with the company’s board and management, discuss strategic priorities, and vote on business items. Shareholders are encouraged to participate actively, either by attending the meeting or by submitting proxy votes in advance. The AGM will also allow for questions to be directed to the company’s auditor, Deloitte Touche Tohmatsu, regarding the financial report and audit conduct.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Limited has announced a change in the director’s interest notice, specifically regarding Andrew Crawfurd Gale’s indirect interest in the company. The change involves the acquisition of 483 ordinary shares, increasing the total number of shares held to 50,483. This transaction was conducted as an on-market trade and reflects a modest increase in the director’s stake, which may indicate confidence in the company’s future performance.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Limited has announced a change in the director’s interest, specifically regarding Anthony Ross Brown. The change involves the acquisition of 69,555 ordinary shares through the conversion of performance rights, increasing the total number of shares held by Mr. Brown to 5,771,764. This adjustment reflects the partial vesting of performance rights under a long-term incentive plan (LTIP), which may influence the company’s governance and shareholder dynamics.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Ltd has issued 144,086 fully paid ordinary shares following the exercise of listed performance rights, as disclosed in their recent ASX release. This move aligns with the company’s compliance with relevant sections of the Corporations Act and reflects its ongoing operational strategies.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Limited announced the cessation of 410,310 performance rights due to the lapse of conditional rights that were not satisfied. This development may impact the company’s capital structure and could have implications for stakeholders regarding the company’s performance metrics and future financial strategies.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Ltd has announced the quotation of 144,086 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of October 9, 2025. This move is part of the company’s strategy to enhance its market presence and provide liquidity to its stakeholders, potentially strengthening its position in the life insurance sector.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.
NobleOak Life Limited announced a change in the director’s interest, as Sarah Jane Brennan increased her indirect interest in the company by acquiring 20,000 ordinary shares through an on-market trade. This change reflects a significant increase in her stake, bringing her total holdings to 40,253 shares, indicating confidence in the company’s future prospects.
The most recent analyst rating on (AU:NOL) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on NobleOak Life Ltd stock, see the AU:NOL Stock Forecast page.